XY8-15949-68385

3 vaccinations 5 coded responses 37 check-ins 4 free-text entries 4 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 100 / NY
Registered: 2021-07-06

Relationship: Self
Race: Multiracial
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2568749 (opens in a new window)	high	9 / 11	—	2 of 10 VAERS symptoms	same dose (3)	NY matches	2022-01-24 / 2022-10-09 / 2023-01-26 received the same day as the last call	case 103263

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-06
Registered in v-safe
2021-07-06
Dose 1 — Pfizer-BioNTech
2021-07-06
Health check-in — day 0, dose 1
Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-07-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-07-08
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness

Adult check-in
2021-07-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-07-10
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-07-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-07-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-07-13
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-07-20
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-07-27
Dose 2 — Pfizer-BioNTech
2021-07-27
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-07-28
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness

Adult check-in
2021-07-29
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-07-31
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness

Adult check-in
2021-08-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-08-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · Fatigue or tiredness

Adult check-in
2021-08-03
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-08-10
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-08-17
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-08-24
Survey response — day 28, dose 2
MedDRA: Dizziness, Headache, Nausea, Oropharyngeal pain, Paranasal sinus discomfort, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Headache, dizziness, nausea, vision changes, sore throat, sinus pressure

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-24
Report sent to call center — day 28, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-25
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-09-01
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-09-07
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-10-26
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2022-01-24
Dose 3 — Pfizer-BioNTech
2022-01-25
Survey response — 6 months, dose 2
MedDRA: Chills, Dizziness, Headache, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Headache, body aches, chills, dizziness (Received booster yesterday 1/24)

MedDRA releases: 2024-11 · check-in free text available
2022-01-26
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-01-27
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2022-01-27
Report sent to call center — days 1–6 daily, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-28
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-01-29
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-01-30
Survey response — days 1–6 daily, dose 3
MedDRA: Palpitations — Feeling: Fair · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Heart palpitations

MedDRA releases: 2024-11 · check-in free text available
2022-01-30
Report sent to call center — days 1–6 daily, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-31
Survey response — day 7, dose 3
MedDRA: Chest discomfort — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Chest tightness

MedDRA releases: 2024-11 · check-in free text available
2022-01-31
Call 2 — Left Voicemail
2022-02-07
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-02-14
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-21
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-02-28
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-03-07
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-04-25
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-07-25
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-01-24
Survey response — 12 months, dose 3
MedDRA: Asthma, COVID-19, Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-24
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-25
Call 1 — Requested Callback
2023-01-26
Call 1 — Left Voicemail
2023-01-26
Call 2 — Left Voicemail
2023-01-26
Callback requested for
03:00PM ET
2023-01-26
Call successful
Completed over the phone
2023-01-26
Call successful
Completed over the phone
2023-01-26
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-06	Pfizer-BioNTech	No
2	2021-07-27	Pfizer-BioNTech	No
3	2022-01-24	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-08-24	Successful 2021-08-25	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-01-27	Successful 2023-01-26	Completed over the phone
2022-01-30	Successful 2023-01-26	Completed over the phone
2023-01-24	Successful 2023-01-26	Completed over the phone

Free text

Release 9 — day 28, dose 2

2021-08-24

Symptoms: Headache, dizziness, nausea, vision changes, sore throat, sinus pressure

Release 11 — 6 months, dose 2

2022-01-25

Symptoms: Headache, body aches, chills, dizziness (Received booster yesterday 1/24)

Release 11 — days 1–6 daily, dose 3

2022-01-30

Systemic reaction (other): Heart palpitations

Release 11 — day 7, dose 3

2022-01-31

Systemic reaction (other): Chest tightness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthma	·	·	✓
SD	Chills	·	·	✓
SD	COVID-19	·	·	✓
SD	Dizziness	✓	·	✓
SD	Headache	✓	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Nausea	✓	·	✓
SD	Oropharyngeal pain	✓	·	✓
SD	Pain	·	·	✓
SD	Paranasal sinus discomfort	✓	·	✓
SD	Visual impairment	✓	·	✓
SRO	Chest discomfort	·	·	✓
SRO	Palpitations	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release